Servier Laboratories (Australia) Pty Ltd

Coveram Plus SR (slow release) has been approved as a substitution therapy for the treatment of hypertension, in patients already controlled with perindopril, amlodipine and indapamide, taken at the same dose level. Coveram Plus SR contains the active ingredients perindopril arginine, amlodipine (as besilate) and indapamide.

Triplixam SR (slow release) has been approved as a substitution therapy for the treatment of hypertension, in patients already controlled with perindopril, amlodipine and indapamide, taken at the same dose level. Triplixam SR contains the active ingredients perindopril arginine, amlodipine (as besilate) and indapamide.

Reaptan Plus SR (slow release) has been approved as a substitution therapy for the treatment of hypertension, in patients already controlled with perindopril, amlodipine and indapamide, taken at the same dose level. Reaptan Plus SR contains the active ingredients perindopril arginine, amlodipine (as besilate) and indapamide.